Shares of Cnova NV (NASDAQ:CNV) have been assigned an average recommendation of “Hold” from the nine research firms that are presently covering the firm. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $4.24.
Separately, Zacks Investment Research raised Cnova NV from a “sell” rating to a “hold” rating in a research note on Tuesday, September 27th.
A number of hedge funds have recently added to or reduced their stakes in CNV. JPMorgan Chase & Co. purchased a new stake in Cnova NV during the second quarter worth about $418,000. Geode Capital Management LLC raised its stake in shares of Cnova NV by 4.9% in the first quarter. Geode Capital Management LLC now owns 177,102 shares of the company’s stock valued at $531,000 after buying an additional 8,229 shares during the period. FMR LLC raised its stake in shares of Cnova NV by 4.8% in the second quarter. FMR LLC now owns 1,729,633 shares of the company’s stock valued at $8,562,000 after buying an additional 79,160 shares during the period. Finally, Boussard & Gavaudan Investment Management LLP raised its stake in shares of Cnova NV by 138.4% in the second quarter. Boussard & Gavaudan Investment Management LLP now owns 1,830,594 shares of the company’s stock valued at $9,153,000 after buying an additional 1,062,702 shares during the period. 1.97% of the stock is owned by institutional investors and hedge funds.
Cnova NV (NASDAQ:CNV) opened at 5.3989 on Wednesday. The stock’s 50 day moving average is $5.33 and its 200 day moving average is $4.71. The firm’s market cap is $2.38 billion. Cnova NV has a one year low of $2.02 and a one year high of $5.41.
Cnova NV (NASDAQ:CNV) last issued its quarterly earnings data on Tuesday, July 26th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.05) by $0.14. Cnova NV had a negative return on equity of 212.82% and a negative net margin of 11.39%. On average, equities research analysts expect that Cnova NV will post ($0.24) earnings per share for the current year.